Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale

MONTEJO, Angel L, DEAKIN, JFW, GAILLARD, Raphael, HARMER, Catherine, MEYNIEL, Florent, JABOURIAN, Artin, GABRIEL, Cecilia, GRUGET, Celine, KLINGE, Corinna, MACFAYDEN, Christine, MILLIGAN, Holly, MULLINGS, Emma and GOODWIN, Guy (2015). Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale. Journal of Psychopharmacology, 29 (10), 1119-1128.

[img]
Preview
PDF
Mullings_Better_Sexual_Acceptability.pdf

Download (325kB) | Preview
Official URL: https://journals.sagepub.com/doi/10.1177/026988111...
Link to published version:: https://doi.org/10.1177/0269881115599385
Related URLs:

    Abstract

    The present double-blind, placebo-controlled study evaluates the effects of agomelatine and the selective serotonin reuptake inhibitor escitalopram on sexual dysfunction in healthy men and women.

    Item Type: Article
    Uncontrolled Keywords: 11 Medical And Health Sciences; 17 Psychology And Cognitive Sciences; Psychiatry
    Identification Number: https://doi.org/10.1177/0269881115599385
    Page Range: 1119-1128
    SWORD Depositor: Symplectic Elements
    Depositing User: Symplectic Elements
    Date Deposited: 21 Jan 2019 10:07
    Last Modified: 17 Feb 2020 09:30
    URI: http://shura.shu.ac.uk/id/eprint/23496

    Actions (login required)

    View Item View Item

    Downloads

    Downloads per month over past year

    View more statistics